ASSOCIATION OF CXCL10 AND CXCL13 IN ACTIVE ADULT ONSET STILL'S DISEASE: EXPRESSION IN SERUM AND SKIN, AND DISEASE ACTIVITY

被引：0
|
作者：
Kim, H. -A. [1 ]
Han, J. H. [2 ]
Suh, C. -H. [1 ]
Jung, J. -Y. [1 ]
机构：
[1] Ajou Univ, Sch Med, Dept Rheumatol, Suwon, South Korea
[2] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3255
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0067
引用
收藏
页码：913 / 913
页数：1
相关论文
共 50 条
  • [41] Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
    Rocha, Natalia Pessoa
    Scalzo, Paula Luciana
    Barbosa, Izabela Guimaraes
    Souza, Mariana Soares
    Morato, Isabela Boechat
    Marciano Vieira, Erica Leandro
    Christo, Paulo Pereira
    Teixeira, Antonio Lucio
    Reis, Helton Jose
    PARKINSONS DISEASE, 2014, 2014
  • [42] CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
    Sivina, Mariela
    Xiao, Lianchun
    Kim, Ekaterina
    Vaca, Alicia
    Chen, Shih-Shih
    Keating, Michael J.
    Ferrajoli, Alessandra
    Estrov, Zeev
    Jain, Nitin
    Wierda, William G.
    Huang, Xuelin
    Chiorazzi, Nicholas
    Burger, Jan A.
    LEUKEMIA, 2021, 35 (06) : 1610 - 1620
  • [43] The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity
    Zeng, Yanli
    Zhang, Yan
    Lin, Yiqiang
    Wang, Xuelian
    Chen, Qinggui
    Huang, Qinghe
    Wang, JiaJia
    Jiang, Longcan
    Xiao, Yun
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (04) : 611 - 619
  • [44] The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity
    Yanli Zeng
    Yan Zhang
    Yiqiang Lin
    Xuelian Wang
    Qinggui Chen
    Qinghe Huang
    JiaJia Wang
    Longcan Jiang
    Yun Xiao
    Clinical and Experimental Medicine, 2021, 21 : 611 - 619
  • [45] CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
    Mariela Sivina
    Lianchun Xiao
    Ekaterina Kim
    Alicia Vaca
    Shih-Shih Chen
    Michael J. Keating
    Alessandra Ferrajoli
    Zeev Estrov
    Nitin Jain
    William G. Wierda
    Xuelin Huang
    Nicholas Chiorazzi
    Jan A. Burger
    Leukemia, 2021, 35 : 1610 - 1620
  • [46] CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behcet's disease
    Lee, Sang Jin
    Kang, Shin Eui
    Kang, Eun Ha
    Choi, Byoong Yong
    Masek-Hammerman, Katherine
    Syed, Jameel
    Zhan, Yutian
    Neff-Phillips, Kathleen
    Park, Jin Kyun
    Lee, Eun Young
    Lee, Eun Bong
    Song, Yeong Wook
    SCIENTIFIC REPORTS, 2017, 7
  • [47] Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease
    Grip, Olof
    Janciauskiene, Sabina
    PLOS ONE, 2009, 4 (05):
  • [48] Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia
    Chen, Jia
    Jia, Ming-nan
    Cai, Hao
    Li, Ze-peng
    Li, Jian
    Zhou, Dao-bin
    Cao, Xin-xin
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3667 - 3675
  • [49] Serum Calprotectin as a Marker for Disease Activity and Severity in Adult-onset Still's Disease
    Jung, Sang-Youn
    Park, Yong-Beom
    Ha, You-Jung
    Lee, Kwang-Hoon
    Lee, Soo-Kon
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1029 - 1034
  • [50] CXCL10 and CXCL13 Expression were Highly Up-regulated in Peripheral Blood Mononuclear Cells in Acute Rejection and Poor Response to Anti-Rejection Therapy
    Mao, Youying
    Wang, Minmin
    Zhou, Qin
    Jin, Juan
    Wang, Yucheng
    Peng, Wenhan
    Wu, Jianyong
    Shou, Zhangfei
    Chen, Jianghua
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 414 - 418
12345